- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05. | Neola Medical AB: Neola Medical Q1 Report 2025 - Strengthened shareholder base with institutional investors ahead of clinical study start | 113 | GlobeNewswire (Europe) | The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximately... ► Artikel lesen | |
| NEOLA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 25.03. | Neola Medical AB: Neola Medical Signs Agreement with Södra Älvsborgs Sjukhus in Borås to Initiate Clinical Pilot Study on Preterm Born Babies | 85 | GlobeNewswire (Europe) | Neola Medical is pleased to announce the signing of a contract with Södra Älvsborgs Sjukhus in Borås, to conduct the company's first clinical pilot study on preterm born babies, with its continuous... ► Artikel lesen | |
| 05.03. | Neola Medical AB: Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring | 147 | GlobeNewswire (Europe) | Neola Medical AB has been granted a patent in China that strengthens the protection of the company's fundamental concept of measuring gases in body cavities using gas absorption spectroscopy for continuous... ► Artikel lesen | |
| 12.02. | Neola Medical AB: Neola Medical Q4 Report 2024 - Received approval for initiation of first clinical pilot study on preterm born babies | 146 | GlobeNewswire (Europe) | Neola Medical achieved key milestones in 2024, instrumental to its planned FDA application: securing the CB certificate and successfully completing the Human Factors Validation study. These accomplishments... ► Artikel lesen | |
| 06.11.24 | Neola Medical AB: Neola Medical Q3 Report 2024 - Intensifying preparations for the first pivotal clinical study on preterm born babies in the U.S. to secure market approval by the FDA | 114 | GlobeNewswire (Europe) | Neola Medical is entering the clinical validation phase and is making significant strides toward securing market approval in the U.S., for continuous lung monitoring device, Neola®. The company's competitive... ► Artikel lesen | |
| 15.08.24 | Neola Medical AB: Neola Medical Q2 Report 2024 - Key milestones meet partial regulatory requirements for FDA approval | 96 | GlobeNewswire (Europe) | Neola Medical reached several critical milestones aligned with its business strategy, aimed at market approval by the FDA. The Human Factors Validation Study with Neola®, was successfully concluded... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 49,830 | +2,68 % | BERENBERG stuft Siemens Healthineers auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Siemens Healthineers von 57,80 auf 57,00 Euro gesenkt, aber die Einstufung auf "Buy" belassen. 2025 sei bislang ein schwieriges... ► Artikel lesen | |
| GENEDX | 91,66 | 0,00 % | Why GeneDx Holdings Stock Blasted 8% Higher Today | ||
| PHETON | 1,630 | 0,00 % | CN ADR Pheton Plummets 95% in Single Day; Report Suggests Possible Manipulation by Overseas Groups | ||
| PRIVIA HEALTH GROUP | 19,480 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 4,130 | 0,00 % | LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer | ||
| FRESENIUS | 42,340 | +0,09 % | Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars | DJ Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars
DOW JONES--Fresenius hat nach eigener Aussage die Zulassung der EU-Kommission für zwei Biosimilars in Europa erhalten.
Wie Fresenius... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 53,85 | 0,00 % | PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO | Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing... ► Artikel lesen | |
| MIMEDX | 6,670 | 0,00 % | SA analyst upgrades/downgrades: OXY, AMZN, MDXG, CHTR | ||
| GERRESHEIMER | 45,600 | -1,08 % | Evotec, Gerresheimer, Hugo Boss, Puma, Renk Group, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 11,780 | 0,00 % | Insights into Alignment Healthcare's Upcoming Earnings | ||
| FRESENIUS MEDICAL CARE | 45,050 | -0,46 % | Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil | DJ Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil
DOW JONES--Fitch Ratings hat die Langfrist-Ratings von Fresenius Medical Care (FMC) mit "BBB-" bestätigt. Der Rating-Ausblick... ► Artikel lesen | |
| UNITEDHEALTH | 228,15 | +0,80 % | UnitedHealth: Justizministerium ermittelt - Aktie unter Druck | Schlechte Nachrichten für die Aktionäre von UnitedHealth: Der US-Gesundheitskonzern hat bestätigt, dass das Justizministerium (DOJ) sowohl straf- als auch zivilrechtliche Ermittlungen gegen das Unternehmen... ► Artikel lesen | |
| NUTEX HEALTH | 84,90 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds to Short Seller Report | HOUSTON, July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 1,060 | 0,00 % | Pre-market Movers: Linkhome, Eightco Holdings, Incannex Healthcare, Coursera, NextCure | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green Linkhome Holdings Inc. (LHAI) is up over 120% at $12.40.
Eightco... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 50,90 | -0,49 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! |
Das Unternehmen NEOLA MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEOLA MEDICAL AB finden Sie auf Wallstreet Online.